Lloyd Emerson Johnson - 05 Aug 2022 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Johnson
Issuer symbol
HAE
Transactions as of
05 Aug 2022
Transactions value $
$0
Form type
4
Filing time
08 Aug 2022, 17:33:49 UTC
Previous filing
28 Jul 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Award +2,730 +89% 5,807 05 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
F2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.